Join the conversation

Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Trending Tickers

BTC logo
Top trending tickerBTC
$60,321.43
2.84%
#1
Bitcoins sharp selloff, reportedly accompanied by heavy leveraged liquidations, and rapid rebound have become the main focus. Traders are divided over whether the bounce marks a durable bottom or a temporary relief rally before further declines.
MRK logo
MRK
$133.72
0.69%
#2
Traders are speculating that Merck could acquire Sellas after Sellas reported positive Phase 3 results for its AML vaccine GPS; Mercks discontinued BELLWAVE blood-cancer program and Keytrudas upcoming patent cliff are cited as possible strategic reasons. No acquisition talks or deal are confirmed, and some traders dismiss the buyout chatter as hype.
LTC logo
LTC
$39.91
0.07%
#3
Litecoins sharp selloff and persistent underperformance versus other cryptocurrencies are driving discussion. Bears warn of further downside after support breaks, while long-term holders are buying the dip and arguing a reversal may be near.
NEAR logo
NEAR
$2.89
2.81%
#4
NEAR is drawing attention amid continued weakness in altcoins, with traders debating whether the token is near a bottom or has further to fall. Some are buying the dip and citing reduced token issuance as a positive, while others remain bearish; discussion also links the broader AI-token move to the market reaction after Anthropics debut.
ZS logo
ZS
$194.82
5.29%
#5
Reports that CrowdStrike is in talks to acquire Zscaler have driven takeover speculation, with traders debating the potential premium and whether a deal would benefit both companies. The discussions remain unconfirmed and could end without an agreement.
RVMD logo
RVMD
$161.20
1.11%
#6
RASONQUEs European approval and strong early U.S. launch uptake are driving attention, with traders weighing the drugs commercial momentum against a share-price pullback and emerging RAS-inhibitor competition. Some remain bullish on the expanding cancer franchise, while others question whether launch performance and clinical differentiation justify the valuation.
SONY logo
SONY
$27.29
0.33%
#7
Sonys reported plan to end physical PlayStation game releases in 2028 is driving debate: critics warn the move could alienate players and push them toward PC, while supporters see cost savings and stronger digital-store margins. The discussion also includes concern about potential subscription cancellations and legal scrutiny of Sonys digital storefront.
SRPT logo
SRPT
$13.33
5.93%
#8
SRPT is under pressure as traders await DM1 and FSHD multiple-ascending-dose readouts, which many see as key to validating the companys siRNA pipeline; recent PepGen DM1 results have also raised questions about the efficacy bar Sarepta must meet. The debate pits optimism about Sareptas existing product revenue and pipeline against concerns about uncertain data, regulatory hurdles, and weakening ELEVIDYS sales.
NTRA logo
NTRA
$273.40
5.70%
#9
Nateras quarterly resultsstrong revenue growth and a raised outlook alongside a wider loss and an abrupt CEO transitionare driving the sharp selloff. Traders are divided between concerns about profitability and leadership uncertainty and the view that testing growth makes the reaction an overreaction.
LINK logo
LINK
$8.64
3.27%
#10
LINK is drawing attention amid sharp swings and uncertain technical momentum, with traders watching support and resistance while debating whether recent weakness is a buying opportunity or part of a deeper decline. Long-term holders point to Chainlinks institutional and tokenization-infrastructure use cases, while skeptics cite underperformance, selling pressure, and dependence on broader crypto-market moves.

About Stocktwits

With over 10 million users, Stocktwits helps you tap into the real-time sentiment and trending insights across stocks, ETFs, and crypto.